Applicant, as named in the Orange Book

Exela Pharma

Next listed expiry: Elcys on 15 Jan 2039. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Elcys · 2 strengths cysteine hydrochloride	cysteine hydrochloride	210660	15 Jan 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (4)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Akovaz · 2 strengths ephedrine sulfate	ephedrine sulfate	208289	open now	no listed protection
Glyrx-Pf · 2 strengths glycopyrrolate	glycopyrrolate	210997	open now	no listed protection
Nipride Rtu In Sodium Chloride 0.9% · 2 strengths sodium nitroprusside	sodium nitroprusside	209387	open now	no listed protection
Tranexamic Acid tranexamic acid	tranexamic acid	212020	open now	no listed protection